Sign Up to like & get
recommendations!
0
Published in 2020 at "Pediatric Nephrology"
DOI: 10.1007/s00467-020-04771-5
Abstract: Rituximab is effective for maintaining remission in patients with complicated nephrotic syndrome, although a history of steroid-resistant nephrotic syndrome (SRNS) is a risk factor for early relapse. We investigated the efficacy of prophylactic rituximab treatment…
read more here.
Keywords:
rituximab;
complicated nephrotic;
prophylaxis group;
treatment ... See more keywords